ABSTRACT Ten patients with ulcerative colitis, all of whom were non-smokers, presented with a productive cough. In six, the chest radiograph was normal and cough was the only symptom; three of these patients had a minor obstructive ventilatory defect on testing. Four patients complained of exertional dyspnoea and had both an abnormal chest radiograph with bilateral pulmonary shadows and a mixed obstructive and restrictive ventilatory defect. Bronchial epithelial biopsies from four patients (two with and two without pulmonary shadows) revealed basal reserve cell hyperplasia, basement membrane thickening, and submucosal inflammation, changes more usually associated with cigarette smoking. Inhaled beclomethasone diproprionate relieved cough in seven patients. The occurrence of airway epithelial disease in association with ulcerative colitis raises the possibility of a systemic mechanism affecting both bronchial and colonic epithelium. It does not seem likely that sulphasalazine was the cause of the pulmonary syndrome in these subjects.
Inflammatory bowel disease, especially ulcerative colitis, is well recognised to be associated with systemic complications. Until recently, the lungs have been considered free from involvement, although there have been reports of patients with alveolitis attributed to sulphasalazine therapy.1 2 Wegner's granulomatosis and pulmonary vasculitis have been described in patients with ulcerative colitis as has a suppurative bronchitis and bronchiectasis, and these syndromes seem unrelated to therapy. [3] [4] [5] [6] fn the present study, 10 patients with ulcerative colitis referred for pulmonary assessment are reported. Four were found to have a previously unreported bronchial epithelial abnormality and seven responded symptomatically to inhaled beclomethasone diproprionate.
Methods
Ten patients, three men and seven women, in whom ulcerative colitis had been previously diagnosed, had respiratory symptoms and were referred for assessment (table 1) . Respiratory function tests included forced expired volume in one second (FEVy) vital capacity (VC) , peak expiratory flow rates (PEER), total lung capacity (TLC), and gas transfer factor for carbon monoxide (TLCO) . In every patient a posterior-anterior and left lateral chest radiograph were also obtained. Autoantibodies and rheumatoid factor were determined, as well as precipitin tests for avian and aspergillus antigens. A peripheral blood film and sputum were inspected for eosinophils. In four patients (patients 3, 4, 9 and 10, table 1) fibreoptic bronchoscopy was performed, specimens of bronchial epithelium were taken from the right anterior basal bronchus and fixed in formaldehyde for routine paraffin sections and in glutaraldehyde for thin ( ltm) plastic sections which were stained with toluidine blue. In one patient (patient 9, table 2) a specimen was also obtained from a raised bronchial mucosal lesion in the left main bronchus. Eight patients were treated with beclomethasone diproprionate by aerosol 100 ,ug four times a day; two of these patients received prednisolone 40 mg per day initially, followed by beclomethasone diproprionate (table 2) .
Results
All patients had undergone rectal biopsy and sigmoidoscopy after the onset of bloody diarrhoea, as well as barium enema studies. The histology of all the rectal lesions was consistent with a diagnosis of ulcerative colitis. In three patients no abnormality was demonstrable in the colon with a barium enema and three other patients required colectomy or hemicolectomy to control the disease (table 1) . No patient described either a clinically noteworthy previous respiratory illness or any history of atopic disorder. 9 showed partially denuded epithelium with aggregations of mixed inflammatory cells below the basement membrane (fig 4) . 
Discussion
Pulmonary disease in association with ulcerative colitis may range from alveolitis to bronchitis,1'5 and we report 10 patients with ulcerative colitis presenting with such a range of pulmonary diseases. Biopsies from all four (two with bronchitis and two with physiological evidence of a restrictive ventilatory defect) showed changes in the bronchial epithelium, consisting of basal cell hyperplasia, basement membrane thickening, submucosal inflammation, and an overall increase in thickness of the epithelium. Changes such as these are usually associated with cigarette smoking," presumably a response to 2 11 sometimes associated with eosinophilia. More recently a purely bronchial disease has been described5 similar to that seen in six of our patients in whom sulphasalazine therapy could not be incriminated. In only two of our patients was the purely alveolitic picture seen (patients 1 and 3), and in both the fact that sulphasalazine had been stopped before the onset of respiratory symptoms had not affected the progress of the condition. The remaining patients had many "bronchial" features, such as a productive cough, airflow obstruction and, in patient 4, bronchiectasis. In only one of these patients was there any temporal relationship between the onset of symptoms and sulphasalazine therapy. In three patients the symptoms began after colectomies had been performed. Furthermore topical steroids relieved symptoms in seven patients, supporting the notion that airway epithelial changes were responsible for the productive cough.
In conclusion, we suggest that there is an association between ulcerative colitis and lung disease in which patients have chronic cough and show hyperplastic and inflammatory changes in their bronchial mucosa. The predominant clinical picture appears more commonly to be a bronchial disease rather than the alveolitis which has previously been described as a reaction to sulphasalazine. Inhaled beclomethasone diproprionate by aerosol appeared to provide satisfactory therapy for the symptoms of this condition.
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